FAF
Fjarde Ap-fonden’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-14,286
| Closed | -$213K | – | 549 |
|
|
2023
Q4 | $213K | Buy |
14,286
+5,800
| +68% | +$86.5K | ﹤0.01% | 534 |
|
|
2023
Q3 | $137K | Sell |
8,486
-14,914
| -64% | -$241K | ﹤0.01% | 538 |
|
|
2023
Q2 | $971K | Hold |
23,400
| – | – | 0.01% | 517 |
|
|
2023
Q1 | $1.41M | Hold |
23,400
| – | – | 0.02% | 486 |
|
|
2022
Q4 | $1.72M | Buy |
23,400
+300
| +1% | +$22K | 0.02% | 477 |
|
|
2022
Q3 | $1.61M | Hold |
23,100
| – | – | 0.02% | 518 |
|
|
2022
Q2 | $1.61M | Sell |
23,100
-9,300
| -29% | -$646K | 0.02% | 518 |
|
|
2022
Q1 | $2.68M | Sell |
32,400
-4,800
| -13% | -$398K | 0.03% | 508 |
|
|
2021
Q4 | $2.79M | Buy |
+37,200
| New | +$2.79M | 0.02% | 511 |
|